X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 M | 2026-10-05 | AGMB | Agomab Therapeutics Nv | Biological Products, (No Diagnostic Substances) | 3 | P - Purchase | $8.70 | +46,000 | 91,217 | +102% | +$399,970 | |||||
| 13 M | 2026-10-19 | BPRE | Bluerock Private Real Estate Fund | Closed-End Funds | 3 | P - Purchase | $12.64 | +2,766,124 | 2,779,890 | >999% | +$34,969,772 | |||||
| 3 | 2026-10-20 | DX | Dynex Capital Inc | Real Estate Investment Trusts | 3 | P - Purchase | $12.01 | +23,680 | 1,505,740 | +2% | +$284,480 | |||||
| 8 DM | 2026-10-16 | FUL | Fuller H B Co | Adhesives & Sealants | 8 | P - Purchase | $49.71 | +22,596 | 46,434 | +95% | +$1,123,318 | |||||
| 7 M | 2026-09-25 | PAM | Pampa Energy Inc. | Electric Services | 3 | P - Purchase | $11.40 | +4,517,122 | 38,946,736 | +13% | +$51,509,548 | |||||
| 13 D | 2026-10-15 | BORR | Borr Drilling Ltd | Drilling Oil & Gas Wells | 3 | P - Purchase | $4.44 | +12,870,500 | 42,087,559 | +44% | +$57,144,458 | |||||
| 3 | 2026-09-22 | DUOT | Duos Technologies Group, Inc. | Prepackaged Software | 2 | P - Purchase | $9.00 | +24,264 | 1,373,773 | +2% | +$218,401 | |||||
| 26 M | 2026-09-18 | BBD | Bank Bradesco | State Commercial Banks | 22 | P - Purchase | $17.45 | +5,760,088 | 24,937,122 | +30% | +$100,491,354 | |||||
| 4 M | 2026-10-14 | INBX | Inhibrx Biosciences, Inc. | Biological Products, (No Diagnostic Substances) | 2 | P - Purchase | $100.54 | +47,540 | 1,197,517 | +4% | +$4,779,777 | |||||
| 2 | 2026-10-07 | ONMD | Onemednet Corp | Commercial Physical & Biological Research | 2 | P - Purchase | $5.72 | +174,884 | 3,011,610 | +6% | +$999,999 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-10-21 | AGMB | Agomab Therapeutics Nv | Epstein David R | Dir | P - Purchase | $8.88 | +10,000 | 25,000 | +67% | +$88,800 | ||||||
2026-10-20 | FBK | Fb Financial Corp | Ingram Orrin H II | Dir | P - Purchase | $52.88 | +29,081 | 124,391 | +31% | +$1,537,788 | ||||||
| M | 2026-10-19 | BPRE | Bluerock Private Real Estate Fund | Kamfar Ramin | Dir | P - Purchase | $12.32 | +271,555 | 2,720,423 | +11% | +$3,345,006 | |||||
2026-10-21 | RAPP | Rapport Therapeutics, Inc. | Ignelzi Troy A. | CFO | P - Purchase | $26.10 | +5,500 | 15,500 | +55% | +$143,550 | ||||||
2026-10-20 | CRF | Cornerstone Total Return Fund Inc | Bradshaw Joshua | Vice COB, Pres | P - Purchase | $5.88 | +20,000 | 20,484 | >999% | +$117,600 | ||||||
2026-10-20 | CLM | Cornerstone Strategic Investment Fund, Inc. | Bradshaw Joshua | Vice COB, Pres | P - Purchase | $6.08 | +16,000 | 20,356 | +367% | +$97,280 | ||||||
2026-10-19 | CRBG | Corebridge Financial, Inc. | Nippon Life Insurance Co | 10% | P - Purchase | $34.51 | +162,024 | 130,010,127 | 0% | +$5,591,238 | ||||||
| M | 2026-10-19 | TENX | Tenax Therapeutics, Inc. | Adar1 Capital Management, LLC | 10% | P - Purchase | $1.59 | +922,849 | 7,447,000 | +14% | +$1,463,426 | |||||
| M | 2026-10-13 | PETV | Petvivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% | P - Purchase | $0.71 | +78,855 | 21,125,803 | 0% | +$56,127 | |||||
| M | 2026-10-20 | NBIS | Nebius Group N.V. | Grimme Arne | Dir | P - Purchase | $166.26 | +299 | 6,628 | +5% | +$49,713 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-10-19 | TENX | Tenax Therapeutics, Inc. | Adar1 Capital Management, LLC | 10% | P - Purchase | $1.59 | +922,849 | 7,447,000 | +14% | +$1,463,426 | |||||
| M | 2026-10-13 | PETV | Petvivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% | P - Purchase | $0.71 | +78,855 | 21,125,803 | 0% | +$56,127 | |||||
2026-10-20 | VRXA | Veraxa Biotech AG - Post De-Spac | Ziegler Christoph Samuel | Dir | P - Purchase | $1.09 | +30,000 | 37,932 | +378% | +$32,700 | ||||||
2026-10-19 | OWLS | Obook Holdings Inc. | Wang Chun Kai | CEO | P - Purchase | $4.27 | +12,192 | 3,137,000 | 0% | +$52,037 | ||||||
| M | 2026-10-16 | BOLD | Boundless Bio, Inc. | Tang Kevin | 10% | P - Purchase | $2.34 | +149,474 | 2,990,109 | +5% | +$349,593 | |||||
| M | 2026-10-09 | EP | Empire Petroleum Corp | Mulacek Phil E | Dir, 10% | P - Purchase | $3.19 | +97,981 | 11,687,503 | +1% | +$312,811 | |||||
| M | 2026-10-15 | SNES | Senestech, Inc. | Glenbrook Capital Management | 10% | P - Purchase | $0.72 | +983,804 | 3,568,392 | +38% | +$706,057 | |||||
| D | 2026-10-15 | CNXU | Conexeu Sciences Inc. | Purcell Lynn Sebastian | Dir, 10% | P - Purchase | $3.00 | +166,666 | 3,118,514 | +6% | +$499,998 | |||||
| M | 2026-10-15 | API | Agora, Inc. | Zhao Bin | CEO | P - Purchase | $4.44 | +17,345 | 85,613,435 | 0% | +$76,930 | |||||
2026-10-09 | ELTP | Elite Pharmaceuticals Inc /Nv/ | Dash Barry H | Dir | P - Purchase | $0.26 | +100,000 | 3,365,555 | +3% | +$25,980 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-10-19 | MAX | Mediaalpha, Inc. | Cramer Keith | Chief Revenue Officer | S - Sale | $11.39 | -12,000 | 239,303 | -5% | -$136,645 | ||||||
| M | 2026-10-19 | MAX | Mediaalpha, Inc. | Nonko Eugene | Dir | S - Sale | $11.57 | -27,639 | 1,604,530 | -2% | -$319,858 | |||||
| M | 2026-10-19 | CRWD | Crowdstrike Holdings, Inc. | Kurtz George | Pres, CEO | S - Sale | $227.90 | -20,000 | 7,821,504 | 0% | -$4,557,951 | |||||
| M | 2026-10-19 | ALMR | Alamar Biosciences, Inc. | Qiming Corporate Gp Vi, Ltd. | 10% | S - Sale | $27.35 | -217,512 | 1,851,350 | -11% | -$5,949,983 | |||||
2026-10-19 | MARA | Mara Holdings, Inc. | Khan Salman Hassan | CFO | S - Sale | $7.88 | -16,000 | 1,889,905 | -1% | -$126,080 | ||||||
| D | 2026-10-19 | SNOW | Snowflake Inc. | Slootman Frank | Dir | S - Sale+OE | $316.43 | -300,000 | 229,053 | -57% | -$94,930,176 | |||||
| DM | 2026-10-19 | ADPT | Adaptive Biotechnologies Corp | Rubinstein Julie | Pres, COO | S - Sale+OE | $24.66 | -35,643 | 377,802 | -9% | -$879,088 | |||||
2026-10-19 | TALO | Talos Energy Inc. | Control Empresarial De Capitales S.A. De C.V. | Add'l Rep. Persons-see Ex.99-1, 10% | S - Sale | $18.01 | -2,141,590 | 24,500,000 | -8% | -$38,562,754 | ||||||
2026-10-19 | META | Meta Platforms, Inc. | Olivan Javier | COO | S - Sale | $707.20 | -1,575 | 94,078 | -2% | -$1,113,840 | ||||||
| M | 2026-10-19 | PACS | Pacs Group, Inc. | Murray Jason Hulse | Co-Founder, CEO, COB, 10% | S - Sale | $47.64 | -45,707 | 54,270,813 | 0% | -$2,177,635 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-10-21 | AGMB | Agomab Therapeutics Nv | Epstein David R | Dir | P - Purchase | $8.88 | +10,000 | 25,000 | +67% | +$88,800 | ||||||
2026-10-16 | ASPI | Asp Isotopes Inc. | Kiessling Heather | CFO | S - Sale | $2.19 | -21,830 | 1,504,422 | -1% | -$47,808 | ||||||
2026-10-19 | MAX | Mediaalpha, Inc. | Cramer Keith | Chief Revenue Officer | S - Sale | $11.39 | -12,000 | 239,303 | -5% | -$136,645 | ||||||
| M | 2026-10-19 | MAX | Mediaalpha, Inc. | Nonko Eugene | Dir | S - Sale | $11.57 | -27,639 | 1,604,530 | -2% | -$319,858 | |||||
| M | 2026-10-19 | CRWD | Crowdstrike Holdings, Inc. | Kurtz George | Pres, CEO | S - Sale | $227.90 | -20,000 | 7,821,504 | 0% | -$4,557,951 | |||||
2026-10-20 | FBK | Fb Financial Corp | Ingram Orrin H II | Dir | P - Purchase | $52.88 | +29,081 | 124,391 | +31% | +$1,537,788 | ||||||
| M | 2026-10-19 | ALMR | Alamar Biosciences, Inc. | Qiming Corporate Gp Vi, Ltd. | 10% | S - Sale | $27.35 | -217,512 | 1,851,350 | -11% | -$5,949,983 | |||||
2026-10-03 | DLTR | Dollar Tree, Inc. | Mitchell John S. Jr | GC | F - Tax | $112.16 | -466 | 19,512 | -2% | -$52,267 | ||||||
2026-10-19 | MARA | Mara Holdings, Inc. | Khan Salman Hassan | CFO | S - Sale | $7.88 | -16,000 | 1,889,905 | -1% | -$126,080 | ||||||
| D | 2026-10-19 | SNOW | Snowflake Inc. | Slootman Frank | Dir | M - OptEx | $8.88 | +300,000 | 229,053 | -423% | +$2,664,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |